Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.4
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Revenue $ 100,000 $ 100,000
Cost of revenue 153,500 460,500
Gross loss (53,500) (360,500)
Operating expenses:        
Research and development 838,967 483,647 2,634,663 1,554,413
Selling, general and administrative 1,857,892 1,428,686 11,455,061 4,297,077
Total operating expenses 2,696,859 1,912,333 14,089,724 5,851,490
Loss from operations (2,696,859) (1,965,833) (14,089,724) (6,211,990)
Other income (expense):        
Other expense (483) (54,709)
Interest expense (340,880) (309,422) (2,664,897) (1,226,021)
Loss on exchange of notes payable for common stock and warrants (1,521,348)
Loss on extinguishment of debt (255,046) (452,646)
Change in fair value of warrant liability (598,899) (1,337,355) 136,326
Change in fair value of derivative liability 38,771 38,771
Total other expense (1,156,537) (309,422) (5,992,184) (1,089,695)
Net loss $ (3,853,396) $ (2,275,255) $ (20,081,908) $ (7,301,685)
Net loss per share, basic and diluted: $ (0.45) $ (0.58) $ (2.70) $ (2.03)
Weighted average shares outstanding, basic and diluted: 8,595,124 3,946,403 7,430,701 3,605,001